Register for Fetch Kansas City
News|Articles|August 24, 2026 (Updated: August 24, 2026)

B. Braun recalls lot of Lactated Ringers injection over particulate contamination

The FDA's Center for Veterinary Medicine flagged the human-labeled recall for veterinary attention, since Lactated Ringers solution is a fluid therapy staple in companion animal, equine, and food-animal practice.

B. Braun Medical Inc has voluntarily recalled a single lot of Excel Lactated Ringers Injection, 1000 mL, after the company identified particulate matter in the solution.1

The contaminants were identified as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene, according to the recall notice posted to the FDA's website August 19, 2026.1

The FDA's Center for Veterinary Medicine (CVM) is circulating the alert to veterinary audiences even though the product carries a human-use label. A balanced electrolyte fluid used to correct dehydration and fluid imbalances, Lactated Ringers solution is a routine part of veterinary fluid therapy across species, administered intravenously or subcutaneously in general practice, emergency, and surgical settings. Facilities that draw fluids from human-labeled inventory, as many veterinary practices and hospitals do, may have received the affected lot.

What's affected

The recalled product is Excel Lactated Ringers Injection, 1000 mL, catalog number L7500, NDC 0264-7750-00, lot J4H077, with an expiration date of November 30, 2026.1

B. Braun distributed the lot nationwide in the United States and to Canada, to hospitals and healthcare facilities, between August 29, 2024, and September 30, 2024.1

Why it matters clinically

Particulate matter administered intravenously carries a mechanical risk independent of the fluid itself. FDA's notice states the defect creates “a reasonable probability” of pulmonary emboli, occlusion of other blood vessels which can potentially lead to tissue death and organ damage, and phlebitis, along with the potential for systemic immune activation, organ dysfunction, and hemolysis.

B. Braun has not received any reports of adverse events tied to this lot as of the recall date.1

What to do

Practices and hospitals should check on-hand IV fluid stock against lot J4H077 (catalog L7500, NDC 0264-7750-00) and quarantine any matching units.

B. Braun says it is notifying affected accounts by mail with instructions for return and replacement; facilities can also reach the company directly at [email protected], Monday through Friday, 8 am to 5 pm EST, with questions about the recall.1

Adverse events or quality problems associated with the product can be reported to FDA MedWatch at 1-800-332-1088 or www.fda.gov/medwatch/report.htm.

References

  1. B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter. News release. FDA. Posted August 19, 2026. Accessed August 24, 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/b-braun-medical-inc-issues-voluntary-north-american-recall-excelr-lactated-ringers-injection-1000ml

Latest CME